Skip to content
Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

Primary Menu Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

  • Home
  • Newswires
  • Politics & Society
  • The New Feudals
  • World View
  • Arts And Aesthetics
  • For The Record
  • About Us
  • Featured

Govt Ready To Start Covid Vaccinations By Next Week

Jan 5, 2021 | Pratirodh Bureau

FILE PHOTO: Health workers prepare a vaccination room inside a school, which has been converted into a temporary COVID-19 vaccination centre, in Ahmedabad, Gujarat

Health authorities are ready to roll out a COVID-19 vaccination programme by next week, the country’s top health official said on Tuesday, days after the drug regulator gave emergency approval to two vaccines.

The government would make the final decision on precisely when to start it, federal health secretary Rajesh Bhushan said.

Meanwhile, a top executive at an Indian biotechnology company defended its COVID-19 vaccine candidate, approved for emergency use by the government, and said it will produce efficacy data from late-stage trials by March.

The vaccine, COVAXIN, received emergency use approval from India’s drugs regulator on Sunday, but the move faced questions after the regulator took the step without publishing information about its efficacy.

Hyderabad-based Bharat Biotech had carried out “200 percent honest clinical trials”, Krishna Ella, chairman and managing director, told reporters in an online address on Monday.

Ella highlighted the company’s experience and expertise in producing vaccines, its numerous patents and its presence in 123 countries.

The approval for COVAXIN, jointly developed with a government institute, was hailed by Prime Minister Narendra Modi and his ministers as a success in India’s self-reliance push.

Efficacy data from the company’s ongoing late-stage trial should be available by March, Ella said.

Health Minister Harsh Vardhan clarified on Twitter on Sunday that the emergency use approval for COVAXIN was “in clinical trial mode”, wherein all recipients of the vaccine would be tracked and monitored as if they were in trial.

The company is also investing in four manufacturing facilities and is planning to make around 200 million doses in Hyderabad and 500 million doses in other cities this year. The company has 20 million available doses so far.

India has the second-highest number of coronavirus infections in the world, though cases have been steadily falling since a peak in September.

India also approved the use of a vaccine developed by AstraZeneca and Oxford University, which will be the lead vaccine in the country’s immunisation programme.

 

Tags: Bharat Biotech, coronavirus, Covaxin, COVID-19, COVID-19 vaccination, Pratirodh

Continue Reading

Previous Google Workers Form Labour Union, A Tech Industry Rarity
Next How Himalayan Dams Turn Into Economic Burdens

More Stories

  • Featured

Jamia Nagar Violence: Court Says The Accused Were Made ‘Scapegoats’

1 day ago Pratirodh Bureau
  • Featured

Originality Is Capacity To Bring Freshness To Old Narratives: Gurnah

2 days ago Pratirodh Bureau
  • Featured

Adani Rise Outcome Of PM Modi’s Patronage: CPI (M)

2 days ago Pratirodh Bureau

Recent Posts

  • Jamia Nagar Violence: Court Says The Accused Were Made ‘Scapegoats’
  • Originality Is Capacity To Bring Freshness To Old Narratives: Gurnah
  • Adani Rise Outcome Of PM Modi’s Patronage: CPI (M)
  • How A United South Asia Can Beat Air Pollution
  • Ban On BBC Docu: SC Directs Govt To Produce Original Records
  • Confronting Himalayan Water Woes Before It Is Too Late
  • No Action Against Hate Speeches Despite Our Orders, Laments SC
  • Budget ’23-’24 Has Very Little For Marginalised Sections: Rights Groups
  • Limiting Global Warming To 1.5 Degrees Is Not Plausible: Report
  • I Struggled: Siddique Kappan After Release
  • Why Has West Given Billions In Aid To Ukraine But Ignored Myanmar?
  • How Riots Formed Kolkata’s Ghettos
  • ‘Callous’ Budget, Hopes Of Majority Betrayed: Chidambaram
  • Kerala College Students Break Taboo Around Sex Education
  • Earth Likely To Cross 1.5-Degree Warming In Next Decade: AI Study
  • Covid-19 Remains ‘Global Health Emergency’, Says WHO
  • Working With Natural Materials To Add To The Sustainable Energy Mix
  • Gandhi’s Image Is Under Scrutiny 75 Years After His Assassination
  • Of India’s Online Schooling Emergency And The Lessons Unlearned
  • Opinion: India Raises The Heat On The Indus Waters Treaty

Search

Main Links

  • Home
  • Newswires
  • Politics & Society
  • The New Feudals
  • World View
  • Arts And Aesthetics
  • For The Record
  • About Us

Related Stroy

  • Featured

Jamia Nagar Violence: Court Says The Accused Were Made ‘Scapegoats’

1 day ago Pratirodh Bureau
  • Featured

Originality Is Capacity To Bring Freshness To Old Narratives: Gurnah

2 days ago Pratirodh Bureau
  • Featured

Adani Rise Outcome Of PM Modi’s Patronage: CPI (M)

2 days ago Pratirodh Bureau
  • Featured

How A United South Asia Can Beat Air Pollution

2 days ago Pratirodh Bureau
  • Featured

Ban On BBC Docu: SC Directs Govt To Produce Original Records

2 days ago Pratirodh Bureau

Recent Posts

  • Jamia Nagar Violence: Court Says The Accused Were Made ‘Scapegoats’
  • Originality Is Capacity To Bring Freshness To Old Narratives: Gurnah
  • Adani Rise Outcome Of PM Modi’s Patronage: CPI (M)
  • How A United South Asia Can Beat Air Pollution
  • Ban On BBC Docu: SC Directs Govt To Produce Original Records
Copyright © All rights reserved. | CoverNews by AF themes.